A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT04444752. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of CBP-201 in adult subjects with moderate to severe atopic dermatitis.
Study identification
- NCT ID
- NCT04444752
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2020 (Actual)
- Primary completion
- Jul 28, 2021 (Actual)
- Completion
- Sep 22, 2021 (Actual)
- Last update posted
- Aug 1, 2023
2020 – 2021
United States locations
- U.S. sites
- 38
- U.S. states
- 15
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connect Investigative Site 310 | Glendale | Arizona | 85308 | — |
| Connect Investigative Site 338 | Phoenix | Arizona | 85001 | — |
| Connect Investigative Site 316 | Tempe | Arizona | 85284 | — |
| Connect Investigative Site 305 | Little Rock | Arkansas | 72204 | — |
| Connect Investigative Site 327 | Canoga Park | California | 91303 | — |
| Connect Investigative Site 324 | Encinitas | California | 92024 | — |
| Connect Investigative Site 301 | Fremont | California | 94538 | — |
| Connect Investigative Site 312 | Huntington Beach | California | 92647 | — |
| Connect Investigative Site 329 | Mission Viejo | California | 92691 | — |
| Connect Investigative Site 322 | San Diego | California | 92123 | — |
| Connect Investigative Site 323 | San Luis Obispo | California | 93405 | — |
| Connect Investigative Site 317 | Santa Ana | California | 92703 | — |
| Connect Investigative Site 318 | Sherman Oaks | California | 91403 | — |
| Connect Investigative Site 325 | Thousand Oaks | California | 91320 | — |
| Connect Investigative Site 332 | Coral Gables | Florida | 33144 | — |
| Connect Investigative Site 320 | Hialeah | Florida | 33016 | — |
| Connect Investigative Site 306 | Hollywood | Florida | 33021 | — |
| Connect Investigative Site 308 | Jacksonville | Florida | 32256 | — |
| Connect Investigative Site 314 | Maitland | Florida | 32751 | — |
| Connect Investigative Site 331 | Miami | Florida | 33155 | — |
| Connect Investigative Site 337 | Miami | Florida | 33155 | — |
| Connect Investigative Site 321 | Miami | Florida | 33173 | — |
| Connect Investigative Site 304 | Orlando | Florida | 32801 | — |
| Connect Investigative Site 340 | Weston | Florida | 33331 | — |
| Connect Investigative Site 333 | Chicago | Illinois | 60640 | — |
| Connect Investigative Site 303 | Chicago | Illinois | 60660 | — |
| Connect Investigative Site 307 | New Albany | Indiana | 47150 | — |
| Connect Investigative Site 313 | West Lafayette | Indiana | 47906 | — |
| Connect Investigative Site 311 | Louisville | Kentucky | 40241 | — |
| Connect Investigative Site 319 | Hunt Valley | Maryland | 21030 | — |
| Connect Investigative Site 335 | Saint Joseph | Missouri | 64506 | — |
| Connect Investigative Site 315 | St Louis | Missouri | 63110 | — |
| Connect Investigative Site 336 | Las Vegas | Nevada | 89109 | — |
| Connect Investigative Site 326 | Albuquerque | New Mexico | 87102 | — |
| Connect Investigative Site 330 | Cincinnati | Ohio | 45231 | — |
| Connect Investigative Site 328 | Rapid City | South Dakota | 57702 | — |
| Connect Investigative Site 309 | Memphis | Tennessee | 38119 | — |
| Connect Investigative Site 334 | Houston | Texas | 77065 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04444752, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04444752 live on ClinicalTrials.gov.